ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Start-Up Nosis Partners Its AI Pl
ScripIdorsia’s hopes of signing a global licensing deal for its hypertension drug Tryvio before the end of the year have been dashed, leaving the cash-strapped Swiss biotech to weigh up “all strategic opti
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Apollo Licenses Ex-China Rights T
Pink SheetAn advisory committee to Japan’s Ministry of Health, Labour and Welfare (MHLW) has recommended the approval of eight new drugs, including a global-first indication for Eisai Co., Ltd. ’s ultra-high d